Clinical Trials for Actavis

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Actavis

Clinical Trials (1)

NCT05577000
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
PHASE1Active, not recruiting
5 participants
Started: Oct 18, 2021 · Completed: Oct 1, 2043
2 conditions4 sponsors1 location